Page last updated: 2024-08-24

tenofovir and Bilateral Headache

tenofovir has been researched along with Bilateral Headache in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angione, SA; Cherian, SM; Özdener, AE1
Andrade-Villanueva, J; Callebaut, C; Cao, H; Cheng, AK; Crofoot, G; Custodio, JM; DeJesus, E; Fordyce, MW; Koenig, E; Martin, H; McCallister, S; Molina, JM; Oka, S; Plummer, A; Podzamczer, D; Post, F; Pozniak, A; Saag, M; Sax, PE; Thompson, M; Trottier, B; Wohl, D; Yin, MT; Zhong, L1
Boeker, K; Eisenbach, C; Felten, G; Hartmann, H; Heyne, R; Hueppe, D; John, C; Krause, W; Leuschner, M; Loehr, HF; Mauss, S; Petersen, J; Ruppert, S; Schiffelholz, W; Schlaak, J; Trautwein, C; Trein, A; Warger, T; Wiese, M1
Bourlière, M; Cadranel, JF; Causse, X; Consoli, SM; Dumortier, J; Hézode, C; Larrey, D; Libert, O; Marcellin, P; Ouzan, D; Pageaux, GP; Pauwels, A; Pétour, P; Riachi, G; Roche, B; Stern, C; Tilliet, V; Truchi, R; Zarski, JP; Zoulim, F1

Reviews

1 review(s) available for tenofovir and Bilateral Headache

ArticleYear
A Review of the Efficacy and Safety of Genvoya® (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection.
    Journal of pharmacy practice, 2018, Volume: 31, Issue:2

    Topics: Anti-HIV Agents; Clinical Trials, Phase III as Topic; Cobicistat; Diarrhea; Disease Management; Drug Combinations; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Headache; HIV Infections; HIV-1; Humans; Nausea; Quinolones; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome

2018

Trials

1 trial(s) available for tenofovir and Bilateral Headache

ArticleYear
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
    Lancet (London, England), 2015, Jun-27, Volume: 385, Issue:9987

    Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Arthralgia; Bone Density; Carbamates; CD4 Lymphocyte Count; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Combinations; Emtricitabine; Female; Headache; HIV Infections; Humans; Kidney; Male; Nausea; Organophosphonates; Quinolones; Respiration Disorders; Sleep Initiation and Maintenance Disorders; Tenofovir; Thiazoles; Treatment Outcome; Viral Load

2015

Other Studies

2 other study(ies) available for tenofovir and Bilateral Headache

ArticleYear
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:10

    Topics: Adult; Antiviral Agents; Creatinine; DNA, Viral; Elasticity Imaging Techniques; Fatigue; Female; Germany; Headache; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Kidney Diseases; Liver; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Tenofovir; Treatment Outcome; Viral Load

2016
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:10

    Topics: Abdominal Pain; Adult; Aged; Antiviral Agents; Asthenia; Diarrhea; DNA, Viral; Female; France; Headache; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Hypophosphatemia; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Nausea; Prospective Studies; Seroconversion; Tenofovir; Treatment Outcome; Viral Load; Vomiting

2016